The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014

Meningococcal Disease

Rosenstein, N. E., Perkins, B. A., Stephens, D. S., Popović, T., & Hughes, J. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441807 · Cited by 1,177 · see citing works

Global epidemiology of meningococcal disease

Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 753 · see citing works

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571 · see citing works

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527401 · Cited by 442 · see citing works

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., & Miller, E. (2003) · BMJ · doi:10.1136/bmj.326.7385.365 · Cited by 409 · see citing works

The changing and dynamic epidemiology of meningococcal disease

Halperin, S. A., Bettinger, J. A., Greenwood, B. M., Harrison, L. H., Jelfs, J., Ladhani, S. N., McIntyre, P. B., Ramsay, M. E., & Sáfadi, M. A. P. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.12.032 · Cited by 307 · see citing works

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment

Vogel, U. F., Taha, M., Vázquez, J. A., Findlow, J., Claus, H., Stefanelli, P., Caugant, D. A., Kriz, P., Abad, R., Bambini, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70006-9 · Cited by 283 · see citing works

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit

Gray, S. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46288-0 · Cited by 221 · see citing works

Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity

Campbell, H. J., Andrews, N. J., Borrow, R., Trotter, C. L., & Miller, E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00529-09 · Cited by 213 · see citing works

Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales

Ladhani, S. N., Beebeejaun, K., Lucidarme, J., Campbell, H. J., Gray, S. J., Kaczmarski, E., Ramsay, M. E., & Borrow, R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu881 · Cited by 208 · see citing works

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain

Larrauri, A., Cano, R., García, M. J. S., & de Mateo, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.045 · Cited by 171 · see citing works

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines

Trotter, C. L., & Ramsay, M. E. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00053.x · Cited by 159 · see citing works

An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015

Lucidarme, J., Scott, K. J., Ure, R., Smith, A. H., Lindsay, D., Stenmark, B., Jacobsson, S., Fredlund, H., Cameron, J. C., Smith‐Palmer, A., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.45.30395 · Cited by 113 · see citing works

Epidemiology of invasive meningococcal disease in the Netherlands, 1960–2012: an analysis of national surveillance data

Bijlsma, M. W., Bekker, V., Brouwer, M. C., Spanjaard, L., van de Beek, D., & ENDE, A. V. D. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70806-0 · Cited by 108 · see citing works

Effectiveness of meningococcal serogroup C vaccine programmes

Borrow, R., Abad, R., Trotter, C., van der Klis, F. R. M., & Vazquez, J. A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.083 · Cited by 88 · see citing works

Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013

Bröker, M., Emonet, S., Fazio, C., Jacobsson, S., Koliou, M., Kuusi, M., Pace, D., Paragi, M., Pysik, A., Simões, M. J., et al. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1051276 · Cited by 63 · see citing works

Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region: July 2013 to December 2014

Aubert, L., Taha, M., Boo, N., Strat, Y. L., Deghmane, A., Sanna, A., Barret, A., Lévy-Bruhl, D., Vandentorren, S., & du Châtelet, I. P. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es2015.20.3.21016 · Cited by 45 · see citing works

Increased incidence of invasive meningococcal disease of serogroup C / clonal complex 11, Tuscany, Italy, 2015 to 2016

Stefanelli, P., Miglietta, A., Pezzotti, P., Fazio, C., Neri, A., Vacca, P., Voller, F., D’Ancona, F. “., Guerra, R., Iannazzo, S., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.12.30176 · Cited by 44 · see citing works

Epidemiology of invasive meningococcal disease in Germany, 2002–2010, and impact of vaccination with meningococcal C conjugate vaccine

Hellenbrand, W., Elias, J., Wichmann, O., Dehnert, M., Frosch, M., & Vogel, U. F. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.09.008 · Cited by 43 · see citing works

Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification

Garrido‐Estepa, M., León-Gómez, I., Herruzo, R., & Cano, R. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.03.010 · Cited by 41 · see citing works

Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century

Kriz, P., Wieffer, H., Holl, K., Rosenlund, M., Budhia, S., & Vyse, A. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.117 · Cited by 37 · see citing works

Characteristics and practices of National Immunisation Technical Advisory Groups in Europe and potential for collaboration, April 2014

Takla, A., Wichmann, O., Carrillo-Santisteve, P., Cotter, S. M., Lévy-Bruhl, D., Paradowska-Stankiewicz, I. A., Valentiner‐Branth, P., D’Ancona, F. “., & Collective the VENICE III NITAG Survey Group (2015) · Eurosurveillance · doi:10.2807/1560-7917.es2015.20.9.21049 · Cited by 30 · see citing works

Meningococcal group C disease in Greece during 1993–2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians

Kafetzis, D. A., Stamboulidis, K., Tzanakaki, G., Kremastinou, J., Skevaki, C. L., Konstantopoulos, A., & Tsolia, M. N. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01704.x · Cited by 27 · see citing works

The Impact of Meningococcal Serogroup C Conjugate Vaccine in Scotland

Mooney, J. D., Christie, P., Robertson, C., & Clarke, S. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421947 · Cited by 26 · see citing works

Risk of Invasive Meningococcal Disease in Men Who Have Sex with Men: Lessons Learned from an Outbreak in Germany, 2012—2013

Hellenbrand, W., Claus, H., Schink, S. B., Marcus, U., Wichmann, O., & Vogel, U. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160126 · Cited by 24 · see citing works

Risk Factors for Serogroup C Meningococcal Disease during Outbreak among Men who Have Sex with Men, New York City, New York, USA

Ridpath, A., Greene, S. K., Robinson, B. F., Weiss, D., & the Meningococcal Investigation Team (2015) · Emerging infectious diseases · doi:10.3201/eid2108.141932 · Cited by 19 · see citing works

Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006–2014

Stefanelli, P., Fazio, C., Neri, A., Boros, S., Renna, G., & Pompa, M. G. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.032 · Cited by 14 · see citing works

Reduction inNeisseria meningitidisinfection in Italy after Meningococcal C conjugate vaccine introduction: A time trend analysis of 1994–2012 series

de Waure, C., Miglietta, A., Nedovic, D., Mereu, G., & Ricciardi, W. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1078951 · Cited by 13 · see citing works

Meningococcal C conjugate age-dependant long-term loss of effectiveness

Garrido‐Estepa, M., Nunez, O. G., León-Gómez, I., Cano, R., & Herruzo, R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.044 · Cited by 10 · see citing works

Teenagers in England to be vaccinated against meningitis group W

Wise, J. (2015) · BMJ · doi:10.1136/bmj.h1486 · Cited by 2 · see citing works

[Sequencing analysis of the antigens included in the four-component vaccine against serogroup B meningococcus in Czech isolates of Neisseria meningitidis from 2007-2013].

Křížová, P., Musílek, M., Vacková, Z., Bečvářová, Z., & Kozáková, J. (2014) · PubMed · Cited by 2 · see citing works

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Cordonnier, C., Einarsdottir, S., Cesaro, S., Blasi, R. D., Mikulska, M., Rieger, C. T., de Lavallade, H., Gallo, G., Lehrnbecher, T., Engelhard, D., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30600-5 · Cited by 334 · see citing works

The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

Parikh, S. R., Campbell, H. J., Bettinger, J. A., Harrison, L. H., Marshall, H. S., Martinón‐Torres, F., Sáfadi, M. A. P., Shao, Z., Zhu, B., von Gottberg, A., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.079 · Cited by 290 · see citing works

Global etiology of bacterial meningitis: A systematic review and meta-analysis.

Oordt-Speets, A. M., Bolijn, R., van Hoorn, R. C., Bhavsar, A., & Kyaw, M. H. (2018) · PloS One · doi:10.1371/journal.pone.0198772 · Cited by 288 · see citing works

Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis

Wang, B., Santoreneos, R., Giles, L. C., Afzali, H. H. A., & Marshall, H. S. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.020 · Cited by 216 · see citing works

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

Ladhani, S. N., Andrews, N. J., Parikh, S. R., Campbell, H. J., White, J. M., Edelstein, M. L., Bai, X., Lucidarme, J., Borrow, R., & Ramsay, M. E. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1901229 · Cited by 215 · see citing works

Epidemiology of community-acquired bacterial meningitis

Brouwer, M. C., & van de Beek, D. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000417 · Cited by 99 · see citing works

Progress toward the global control of Neisseria meningitidis : 21st century vaccines, current guidelines, and challenges for future vaccine development

Dretler, A. W., Rouphael, N., & Stephens, D. S. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1451810 · Cited by 87 · see citing works

First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England

Ladhani, S. N., Campbell, H. J., Andrews, N. J., Parikh, S. R., White, J. M., Edelstein, M. L., Clark, S. A., Lucidarme, J., Borrow, R., & Ramsay, M. E. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1244 · Cited by 80 · see citing works

Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children

Castilla, J., Cenoz, M. G., Abad, R., Sánchez-Cambronero, L., Lorusso, N., Izquierdo, C., Llabrés, S. C., Roig, J., Malvar, A., Carril, F. G., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2206433 · Cited by 71 · see citing works

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines

Villena, R., Sáfadi, M. A. P., Valenzuela, M. T., Torres, J. P., Finn, A. H. R., & O’Ryan, M. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1458175 · Cited by 58 · see citing works

Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database

Taha, M., Weil-Olivier, C., Bouée, S., Emery, C., Nachbaur, G., Pribil, C., & Loncle-Provot, V. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1849518 · Cited by 56 · see citing works

Validation of a Bioinformatics Workflow for Routine Analysis of Whole-Genome Sequencing Data and Related Challenges for Pathogen Typing in a European National Reference Center: Neisseria meningitidis as a Proof-of-Concept

Bogaerts, B., Winand, R., Fu, Q., Braekel, J. V., Ceyssens, P., Mattheus, W., Bertrand, S., Keersmaecker, S. C. J. D., Roosens, N. H. C., & Vanneste, K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00362 · Cited by 54 · see citing works

Molecular diagnostic assays for the detection of common bacterial meningitis pathogens: A narrative review

Diallo, K., Feteh, V. F., Ibe, L., Antonio, M., Caugant, D. A., du Plessis, M., Deghmane, A.-E., Feavers, I. M., Fernandez, K., Fox, L. M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103274 · Cited by 51 · see citing works

Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations

Martinón‐Torres, F., Taha, M., Knuf, M., Abbing‐Karahagopian, V., Pellegrini, M., Bekkat-Berkani, R., & Abitbol, V. (2021) · Pathogens and Global Health · doi:10.1080/20477724.2021.1972663 · Cited by 51 · see citing works

Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling study

Campbell, H., Andrews, N., Parikh, S. R., White, J., Edelstein, M. L., Bai, X., Lucidarme, J., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00335-7 · Cited by 48 · see citing works

Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010–2015

Parikh, S. R., Campbell, H. J., Gray, S. J., Beebeejaun, K., Ribeiro, S., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.038 · Cited by 47 · see citing works

Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review

Deghmane, A., Taha, S., & Taha, M. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1971289 · Cited by 44 · see citing works

Serogroup-specific meningococcal carriage by age group: a systematic review and meta-analysis

Peterson, M. E., Li, Y., Shanks, H., Mile, R., Nair, H., & Kyaw, M. H. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024343 · Cited by 44 · see citing works

Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature

Guedes, S., Bertrand-Gerentes, I., Evans, K. E., Coste, F., & Oster, P. (2022) · BMC Public Health · doi:10.1186/s12889-022-12795-9 · Cited by 43 · see citing works

Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern Europe

Bai, X., Borrow, R., Bukovski, S., Caugant, D. A., Culic, D., Delic, S., Dinleyici, E. Ç., Eloshvili, M., Erdősi, T., Galajeva, J., et al. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.10.018 · Cited by 41 · see citing works

Immunogenicity, safety and inter-lot consistency of a meningococcal conjugate vaccine (MenACYW-TT) in adolescents and adults: A Phase III randomized study

Dhingra, M. S., Peterson, J., HEDRICK, J. A., Pan, J., Neveu, D., & Jordanov, E. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.06.013 · Cited by 40 · see citing works

Product review on the IMD serogroup B vaccine Bexsero®

Deghmane, A., & Taha, M. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2020043 · Cited by 39 · see citing works

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study

Vesikari, T., Borrow, R., Forstén, A., Findlow, H., Dhingra, M. S., & Jordanov, E. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1733869 · Cited by 39 · see citing works

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in ≥56-year-olds: A Phase III randomized study

Esteves-Jaramillo, A., Koehler, T., Jeanfreau, R. J., Neveu, D., Jordanov, E., & Dhingra, M. S. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.04.067 · Cited by 38 · see citing works

The nonpathogenic commensal Neisseria: friends and foes in infectious disease

Dorey, R. B., Theodosiou, A. A., Read, R. C., & Jones, C. E. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000585 · Cited by 37 · see citing works

Risk of sequelae after invasive meningococcal disease

Voss, S. S., Nielsen, J. O., & Valentiner‐Branth, P. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07129-4 · Cited by 37 · see citing works

Influenza Increases Invasive Meningococcal Disease Risk in Temperate Countries

Salomon, A., Berry, I., Tuite, A. R., Drews, S. J., Hatchette, T. F., Jamieson, F., Johnson, C., Kwong, J. C., Lina, B., Lojo, J., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.004 · Cited by 36 · see citing works

Whole-Genome Sequencing for Characterization of Capsule Locus and Prediction of Serogroup of Invasive Meningococcal Isolates

Marjuki, H., Topaz, N., Rodriguez‐Rivera, L. D., Ramos, E., Cubeñas-Potts, C., Chen, A. J., Retchless, A. C., Doho, G., & Wang, X. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01609-18 · Cited by 35 · see citing works

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018

Loenenbach, A. D., ENDE, A. V. D., de Melker, H. E., Sanders, E. A. M., & Knol, M. J. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz578 · Cited by 35 · see citing works

An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine

Keshavan, P., Pellegrini, M., Vadivelu, K., & Nissen, M. D. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1521280 · Cited by 34 · see citing works

Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience

Isitt, C. E., Cosgrove, C. A., Ramsay, M. E., & Ladhani, S. N. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-318047 · Cited by 34 · see citing works

Asymptomatic carriage of Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae, Group A Streptococcus and Staphylococcus aureus among adults aged 65 years and older

Drayß, M., Claus, H., Hubert, K., Thiel, K., Berger, A., Sing, A., van der Linden, M., Vogel, U. F., & Lâm, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212052 · Cited by 34 · see citing works

Meningococcal disease epidemiology in Brazil (2005–2018) and impact of MenC vaccination

Nunes, A. A., de Abreu, A. D. J. L., Cintra, O. A. L., Cintra, M. A. C. T., Coelho, E. B., & de Barros, E. N. C. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.11.067 · Cited by 33 · see citing works

Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database

Weil-Olivier, C., Taha, M., Emery, C., Bouée, S., Beck, E. C., Aris, E., Loncle-Provot, V., Nachbaur, G., & Pribil, C. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00468-w · Cited by 33 · see citing works

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study

Kirstein, J. L., Pina, M., Pan, J., Jordanov, E., & Dhingra, M. S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1733868 · Cited by 29 · see citing works

Meningococcal carriage in Norwegian teenagers: strain characterisation and assessment of risk factors

Watle, S. V., Caugant, D. A., Tunheim, G., Bekkevold, T., Laake, I., Brynildsrud, O. B., & Næss, L. M. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820000734 · Cited by 28 · see citing works

Acute Community-Acquired Bacterial Meningitis

Figueiredo, A. H. A., Brouwer, M. C., & van de Beek, D. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.06.007 · Cited by 27 · see citing works

Changing patterns of invasive meningococcal disease and future immunization strategies

Taha, M., Bekkat-Berkani, R., & Abitbol, V. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2186111 · Cited by 27 · see citing works

Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy

Pezzotti, P., Miglietta, A., Neri, A., Fazio, C., Vacca, P., Voller, F., Rezza, G., & Stefanelli, P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.002 · Cited by 25 · see citing works

Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK

Ladhani, S. N., Andrews, N. J., & Ramsay, M. E. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30492-8 · Cited by 24 · see citing works

Meningitis in Children: Still a Can’t-Miss Diagnosis

Skar, G. L., Flannigan, L., Latch, R. L., & Snowden, J. A. (2024) · Pediatrics in Review · doi:10.1542/pir.2023-006013 · Cited by 23 · see citing works

Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England

Beck, E. C., Klint, J., Garcia, S., Abbing‐Karahagopian, V., Abitbol, V., Åkerborg, Ö., Argante, L., Bekkat-Berkani, R., Hogea, C. S., Neine, M. E. M., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.08.007 · Cited by 23 · see citing works

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16

Findlow, H., Campbell, H. J., Lucidarme, J., Andrews, N. J., Linley, E., Ladhani, S. N., & Borrow, R. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.1.1700818 · Cited by 22 · see citing works

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Piazza, F. M., Virta, M., Paassilta, M., Ukkonen, B., Ahonen, A., Esteves-Jaramillo, A., Forstén, A., Seppä, I., Ding, J., Neveu, D., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1902701 · Cited by 21 · see citing works

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup BNeisseria meningitidisIsolated from 2009 to 2013 in the Republic of Ireland

Mulhall, R., Bennett, D. E., Cunney, R., Borrow, R., Lucidarme, J., Findlow, J., Jolley, K. A., Bray, J. E., Maiden, M. C. J., Moschioni, M., et al. (2018) · mSphere · doi:10.1128/msphere.00196-18 · Cited by 20 · see citing works

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study

Robertson, C. A., Jacqmein, J., Selmani, A., Galarza, K., & Oster, P. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2160600 · Cited by 19 · see citing works

Real-world impact and effectiveness of MenACWY-TT

Villena, R., Kriz, P., Htar, M. T. T., Burman, C., Findlow, J., Balmer, P., & Jódar, L. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2251825 · Cited by 19 · see citing works

Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study

Dbaibo, G. S., Tinoco, J. C., Traskine, M., Jastorff, A. M., & der Wielen, M. V. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.046 · Cited by 19 · see citing works

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database

Weil-Olivier, C., Taha, M., Bouée, S., Emery, C., Loncle-Provot, V., Nachbaur, G., Beck, E. C., & Pribil, C. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2021764 · Cited by 18 · see citing works

Overview of meningococcal epidemiology and national immunization programs in children and adolescents in 8 Western European countries

Cardoso, G. P., Lagrée-Chastan, M., Caséris, M., Gaudelus, J., Haas, H., Leroy, J., Bakhache, P., Pujol, J.-F., Werner, A., Dommergues, M., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1000657 · Cited by 18 · see citing works

Infection is associated with one in five childhood deaths in England and Wales: analysis of national death registrations data, 2013–15

Ferreras-Antolin, L., Oligbu, G., Okike, I. O., & Ladhani, S. N. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-318001 · Cited by 18 · see citing works

Intercomparison of Aerosol Types Reported as Part of Aerosol Product Retrieval over Diverse Geographic Regions

Falah, S., Mhawish, A., Omar, A. H., Sorek‐Hamer, M., Lyapustin, A., Banerjee, T., Kizel, F., & Broday, D. M. (2022) · Remote Sensing · doi:10.3390/rs14153667 · Cited by 18 · see citing works

Epidemiology and economic burden of meningococcal disease in Germany: A systematic review

Gruhn, S., Witte, J., Greiner, W., Damm, O., Dietzsch, M., Kramer, R., & Knuf, M. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.02.043 · Cited by 17 · see citing works

Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review

Bertrand-Gerentes, I., Fanchon, L., Coste, F., Glover, R. E., Guiddir, T., & Taha, M. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00869-z · Cited by 16 · see citing works

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study

Zambrano, B., Peterson, J., Deseda, C. C., Julien, K., Spiegel, C. A., Seyler, C., Simon, M. W., Hoki, R., Anderson, M., Brabec, B., et al. (2023) · Pediatric Research · doi:10.1038/s41390-023-02478-5 · Cited by 15 · see citing works

Introduction of a second MenB vaccine into Europe – needs and opportunities for public health

Findlow, J., Nuttens, C., & Kriz, P. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1578217 · Cited by 15 · see citing works

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study

Chiu, N., Huang, L., Willemsen, A., Bhusal, C., Arora, A. K., Mojares, Z. R., & Toneatto, D. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1425659 · Cited by 14 · see citing works

Meningococcal vaccination in pregnancy

Raya, B. A., & Sadarangani, M. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1445447 · Cited by 14 · see citing works

Meningococcal Disease in Pediatric Age: A Focus on Epidemiology and Prevention

Pietro, G. M. D., Biffi, G., Castellazzi, M. L., Tagliabue, C., Pinzani, R., Bosis, S., & Marchisio, P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074035 · Cited by 14 · see citing works

Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010–2016

Lee, H., Seo, Y., Kim, K., Lee, K., & Choe, K. W. (2018) · Scientific Reports · doi:10.1038/s41598-018-23365-8 · Cited by 14 · see citing works

Timeliness of routine immunization in non-preterm children less than 2 years old using electronic data capture in an ambulatory setting in France in the context of vaccine hesitancy

Rybak, A., le Sage, F. V., Béchet, S., Werner, A., Thiebault, G., Bakhache, P., Virey, B., Caulin, E., Cohen, R., & Lévy, C. (2019) · Archives de Pédiatrie · doi:10.1016/j.arcped.2018.11.011 · Cited by 13 · see citing works

4CMenB vaccine and its role in preventing transmission and inducing herd immunity

McMillan, M., Marshall, H. S., & Richmond, P. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2003708 · Cited by 13 · see citing works

Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis

Deghmane, A., Hong, E., & Taha, M. (2023) · Antibiotics · doi:10.3390/antibiotics12060992 · Cited by 13 · see citing works

Estimation of the real burden of invasive meningococcal disease in Argentina

Gomez, J. A., Malbrán, P. W., Vidal, G., Seoane, M., & Giglio, N. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819002024 · Cited by 13 · see citing works

Phenotypic and genotypic characterization of meningococcal isolates in Tunis, Tunisia: High diversity and impact on vaccination strategies

Brik, A., Terrade, A., Hong, E., Deghmane, A., Taha, M., Bouafsoun, A., Khmiri, M., Boussetta, K., Boukhir, S., Jaballah, N. B., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.11.013 · Cited by 12 · see citing works

Societal costs due to meningococcal disease: a national registry-based study

Gustafsson, N., Stallknecht, S. E., Skovdal, M., Poulsen, P. B., & Østergaard, L. (2018) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s175835 · Cited by 12 · see citing works

Study of the Immune Response in the Elderly: Is It Necessary to Develop a Vaccine againstNeisseria meningitidisfor the Aged?

de Lima, G. T., & Gaspari, E. D. (2019) · Journal of Aging Research · doi:10.1155/2019/9287121 · Cited by 12 · see citing works

Characterization of invasive Neisseria meningitidis isolates recovered from children in Turkey during a period of increased serogroup B disease, 2013–2017

Ceyhan, M., Özsürekçi, Y., Lucidarme, J., & Borrow, R. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.03.024 · Cited by 12 · see citing works

Vaccines and Senior Travellers

Ecarnot, F., Maggi, S., Michel, J., Veronese, N., & Rossanese, A. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.677907 · Cited by 12 · see citing works

Invasive meningococcal disease epidemiology and vaccination strategies in four Southern European countries: a review of the available data

Zografaki, I., Detsis, M., del Amo, M., Iantomasi, R., Maia, A., Montuori, E. A., & Méndez, C. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2225596 · Cited by 12 · see citing works

A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease

Marten, O., Koerber, F., Bloom, D. E., Bullinger, M., Buysse, C. M. P., Christensen, H., Wals, P. D., Dohna‐Schwake, C., Henneke, P., Kirchner, M., et al. (2019) · Health and Quality of Life Outcomes · doi:10.1186/s12955-019-1159-0 · Cited by 12 · see citing works

Genetic variability of Polish serogroup B meningococci (2010–2016) including the 4CMenB vaccine component genes

Waśko, I., Gołębiewska, A., Kiedrowska, M., Ronkiewicz, P., Wróbel-Pawelczyk, I., Kuch, A., Hong, E., & Skoczyńska, A. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.021 · Cited by 12 · see citing works

Prevalence and Characteristics of Carriage of Neisseria meningitidis Among Young Israeli Adults

Sofer-Sali, N., Roif-Kaminsky, D., Motro, Y., Khalfin, B., Avramovich, E., Galor, I., Shlaifer, A., Sommer, A. C., Rutenberg, R., Sachter, Y., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac482 · Cited by 11 · see citing works

MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial

Rivera, L., Chanthavanich, P., Põder, A., Suryakiran, P. V., Jastorff, A. M., & der Wielen, M. V. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.051 · Cited by 11 · see citing works

Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016

Bennett, D. E., O’Lorcain, P. P., Morgan, S., Cotter, S. M., Cafferkey, M., & Cunney, R. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819000396 · Cited by 11 · see citing works

The Epidemiology of Meningococcal Disease and Carriage, Genotypic Characteristics and Antibiotic Resistance of Neisseria meningitidis Isolates in Zhejiang Province, China, 2011–2021

Zhang, Y., Deng, X., Jiang, Y., Zhang, J., Li, Z., Mei, L., Lu, H.-J., Yao, P., & He, H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.801196 · Cited by 11 · see citing works

Increase of Neisseria meningitidis W:cc11 invasive disease in Chile has no correlation with carriage in adolescents

Rubilar, P. S., Barra, G. N., Gabastou, J.-M., Alarcón, P., Araya, P., Hormazábal, J. C., & Fernández, J. O. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193572 · Cited by 11 · see citing works

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines

Serra, L., Knuf, M., Martinón‐Torres, F., Yi, K., & Findlow, J. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1855952 · Cited by 10 · see citing works

Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in England

Ladhani, S. N., Campbell, H. J., Amin‐Chowdhury, Z., Lucidarme, J., Borrow, R., & Ramsay, M. E. (2022) · Vaccine · doi:10.1016/j.vaccine.2021.12.010 · Cited by 10 · see citing works

Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines

Stein‐Zamir, C., Shoob, H., Abramson, N., Block, C., Keller, N., Jaffe, J., & Valinsky, L. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1507261 · Cited by 10 · see citing works

Invasive Meningococcal Disease on the Workplaces: a systematic review.

Riccò, M., Vezzosi, L., Odone, A., & Signorelli, C. (2017) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v88i3.6726 · Cited by 10 · see citing works

Sustained reductions of invasive infectious disease following general infant Haemophilus influenzae type b and pneumococcal vaccination in a Swedish Arctic region

Kostenniemi, U. J., Norman, D., Sellin, M., & Silfverdal, S. (2019) · Acta Paediatrica · doi:10.1111/apa.14824 · Cited by 10 · see citing works

Invasive Meningococcal Disease in Italy: from the analysis of national data to an evidence-based vaccination strategy.

Igidbashian, S., Bertizzolo, L., Tognetto, A., Azzari, C., Bonanni, P., Castiglia, P., Conversano, M., Esposito, S., Gabutti, G., Icardi, G., et al. (2020) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2020.61.2.1589 · Cited by 9 · see citing works

Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review

Kassianos, G. C., Barasheed, O., Abbing‐Karahagopian, V., Khalaf, M., Öztürk, S., Banzhoff, A., & Badur, S. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00836-8 · Cited by 9 · see citing works

Epidemiology and Clinical Burden of Meningococcal Disease in France: Scoping Review

Baloche, A., Dussart, C., Bedouch, P., Carrouel, F., & Mick, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030849 · Cited by 9 · see citing works

Meningococcal C vaccine coverage in France in infants, children, and adolescents

Gaudelus, J., Cohen, R., Leboucher, B., Stahl, J. ‐., Denis, F., Pujol, P., Longfier, L., & Martinot, A. (2019) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2019.01.014 · Cited by 9 · see citing works

Genomic surveillance of invasive meningococcal disease in the Czech Republic, 2015-2017

Křížová, P., & Honskus, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219477 · Cited by 9 · see citing works

Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland

Léo, S., Lazarević, V., Girard, M., Velasco, G. C. G.-J., Gaïa, N., Renzi, G., Cherkaoui, A., Hong, E., Taha, M., & Schrenzel, J. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.05.071 · Cited by 9 · see citing works

A Laboratory-Based Surveillance Study of Invasive Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae Diseases in a Serbian Pediatric Population—Implications for Vaccination

Delic, S., Mijač, V., Gajić, I., Kekić, D., Ranin, L. T., Jegorović, B., Culic, D., Ćirković, V., Šiljić, M., Stanojević, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11061059 · Cited by 8 · see citing works

Growing evidence supports 4CMenB effectiveness

Ladhani, S. N., Borrow, R., & Andrews, N. J. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30051-3 · Cited by 8 · see citing works

Epidemiology of invasive meningococcal disease in Greece, 2006–2016

Members of the Hellenic network for Invasive meningococcal disease, Flountzi, A., Georgakopoulou, T., Balasegaram, S., Κεσανόπουλος, Κ., Xirogianni, A., Papandreou, A., & Tzanakaki, G. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03668-y · Cited by 8 · see citing works

Tobacco smoking and meningococcal disease in adolescents and young adults: a systematic review and meta-analysis

Pilat, E. K., Stuart, J. M., & French, C. E. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.02.018 · Cited by 8 · see citing works

A retrospective assessment of the completeness and timeliness of meningococcal disease notifications in the Republic of Ireland over a 16-year period, 1999–2015

O’Lorcain, P. P., Bennett, D. E., Morgan, S., Cunney, R., Cotter, S. M., CAFFERKEY, M. T., & O’Flanagan, D. (2018) · Public Health · doi:10.1016/j.puhe.2017.11.027 · Cited by 8 · see citing works

Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0

Bidmos, F. A., Nadel, S., Screaton, G. R., Kroll, J. S., & Langford, P. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01621 · Cited by 8 · see citing works

Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?

Mauskopf, J., Masaquel, C., & Huang, L. (2020) · Value in Health · doi:10.1016/j.jval.2020.06.018 · Cited by 8 · see citing works

Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents

Biolchi, A., Tomei, S., Santini, L., Gaetana, R. L., Mori, E., Novy, P., Rappuoli, R., Bekkat-Berkani, R., Giuliani, M. M., & Pizza, M. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002957 · Cited by 7 · see citing works

Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993–2020)

Honskus, M., Křížová, P., Okonji, Z., Musílek, M., & Kozáková, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282971 · Cited by 7 · see citing works

Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?

Tzanakaki, G., Cabrnochová, H., Delić, S., Drăgănescu, A. C., Hilfanova, A., Ónozó, B., Pokorn, M., Skoczyńska, A., & Tešović, G. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2301186 · Cited by 7 · see citing works

Use of Cost-Effectiveness Analyses for Decisions About Vaccination Programs for Meningococcal Disease in the United States, United Kingdom, The Netherlands, and Canada

Huang, L., Mauskopf, J., Farkouh, R., & Masaquel, C. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1878030 · Cited by 7 · see citing works

Metagenomic data from cerebrospinal fluid permits tracing the origin and spread of Neisseria meningitidis CC4821 in China

Chen, H., Li, M., Tu, S., Zhang, X., Wang, X., Zhang, Y., Zhao, C., Guo, Y., & Wang, H. (2022) · Communications Biology · doi:10.1038/s42003-022-03792-0 · Cited by 7 · see citing works

Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017

Nuttens, C., Findlow, J., Balmer, P., Swerdlow, D. L., & Htar, M. T. T. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.3.2002075 · Cited by 40 · see citing works

The Impact of Routine Immunization Using Meningococcal C Conjugate Vaccine on Invasive Meningococcal Disease in British Columbia

Siu, T. O., Tang, W., Dawar, M., & Patrick, D. M. (2008) · Canadian Journal of Public Health · doi:10.1007/bf03405245 · Cited by 19 · see citing works

Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006–2014

Stefanelli, P., Fazio, C., Neri, A., Boros, S., Renna, G., & Pompa, M. G. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.032 · Cited by 14 · see citing works

Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006–2015

du Châtelet, I. P., Deghmane, A., Antona, D., Hong, E., Fonteneau, L., Taha, M., & Lévy-Bruhl, D. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.02.011 · Cited by 59 · see citing works

Epidemiology of invasive meningococcal disease in Germany, 2002–2010, and impact of vaccination with meningococcal C conjugate vaccine

Hellenbrand, W., Elias, J., Wichmann, O., Dehnert, M., Frosch, M., & Vogel, U. F. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.09.008 · Cited by 43 · see citing works